在PD-L1糖化中的变化在黑色素瘤中塑造了抗瘤免疫反应
Long Liang1,2, Xinwei Kuang1,3, Yi He1,3
1Department of Dermatology, Xiangya Hospital & School of Life Sciences & Furong Laboratory, Central South University, Changsha, China.
Nature genetics
|March 12, 2025
概括
瘤中的代谢重编程涉及顺-CoA,这是与改善抗编程细胞死亡蛋白-1 (PD-1) 疗法相关的代谢物. 增加 succinyl-CoA可增强T细胞免疫力和PD-L1降解,增强抗瘤活性.
科学领域:
- 癌症新陈代谢 癌症新陈代谢
- 免疫学 免疫学 免疫学
- 线粒体功能的功能
背景情况:
- 瘤重编程新陈代谢以促进生长,但线粒体新陈代谢在瘤免疫力中的作用尚不清楚.
- 代谢重编程对于恶性瘤至关重要,影响能量,合成和氧化还原需求.
- 了解影响瘤免疫力的代谢途径是新治疗策略的关键.
研究的目的:
- 研究线粒体代谢和瘤免疫之间的联系.
- 确定基尼尔-CoA在抗瘤免疫力和抗PD-1疗法的作用.
- 确定代谢物影响黑色素瘤免疫反应的机制.
主要方法:
- 空间转录学,批量转录学和蛋白质学的综合分析.
- 在体外和体内实验中使用T细胞和瘤模型进行实验.
- 评估了代谢物补充剂 (α-甲酸盐,糖酸盐) 和药物治疗 (贝萨纤维酸盐) 的影响.
主要成果:
- 在黑色素瘤中,顺-CoA水平,瘤免疫力和抗PD-1治疗反应之间发现了强烈的相关性.
- 升高的顺-CoA增强了T细胞介导的瘤消除.
- 通过CPT1A对PD-L1的顺化导致PD-L1的降解,增强了抗瘤活性.
- 贝扎菲布拉特上调了CPT1A,并与抗CTLA-4疗法协同作用.
结论:
- 苏奇尼尔-CoA是一种关键的代谢物,将线粒体代谢与瘤免疫和抗PD-1疗法联系起来.
- 通过CPT1A介导的PD-L1化是一种增强抗瘤反应的新机制.
- 在黑色素瘤中,CPT1A和PD-L1水平可以作为抗PD-1疗法疗效的预测生物标志物.
更多相关视频
07:04Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
212
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.1K
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:31The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
02:04Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K